Trifluoroacetyl Tripeptide-2

Firmness / Aging

INCI: Trifluoroacetyl Tripeptide-2

Effect

Progerin accumulation suppression, sagging improvement

Mechanism

Progerin production suppression → Nuclear membrane stabilization

Typical concentration

Stock solution 2-4%

Onset

4-8 weeks

Cautions

Relatively new ingredient

Evidence & references

Scaffidi & Misteli (2006) Science [PubMed] as basic research on progerin accumulation in aging. Note: this paper demonstrates progerin's role in normal aging and is NOT a clinical trial of this peptide's efficacy; efficacy evidence for the ingredient itself is mainly manufacturer-derived and limited.

This page is reference information and does not guarantee efficacy. Figures vary by test conditions (in vitro / manufacturer / concentration). It does not indicate pharmaceutical efficacy.

← Back to Ingredients